Certuma
Category: AI in Healthcare
Building the first FDA-approved AI doctor for diagnosing and prescribing treatments for common low-risk medical conditions. Certuma was founded in 2026. The company is led by Martin Varsavsky. Based in Austin, Texas, United States. Team size: 11-50. Total funding raised: $10M. Latest round: Seed. Key investors include 8VC (led by Joe Lonsdale).
- Founded
- 2026
- Headquarters
- Austin, Texas, United States
- Team size
- 11-50
- Total funding
- $10M
Value proposition
Physician-verified clinical decisions at machine speed — combining AI autonomy with deterministic safety gates and licensed physician oversight to deliver auditable, legally recognized medical diagnoses and prescriptions.
Products and solutions
Autonomous Clinical Infrastructure — an AI platform that turns patient symptom narratives into structured clinical records, runs deterministic safety checks, and prepares in-scope plans for licensed physicians to review and sign. Targets 25 low-risk conditions initially (UTIs, sore throats, sinusitis, conjunctivitis, etc.). Uses Hybrid Deterministic Architecture combining LLM reasoning with a hard validation layer (MedCanon).
Unique value
First AI doctor seeking formal FDA approval with a Hybrid Deterministic Architecture that ensures every clinical decision is physician-verified, auditable, and regulatory-aligned — addressing the global physician shortage while maintaining safety accountability.
Target customer
Healthcare providers including hospitals and clinics; patients seeking rapid diagnosis and treatment for common low-risk conditions
Industries served
Healthcare (primary care, urgent care, telemedicine)
Technology advantage
MedCanon deterministic clinical reasoning layer; Hybrid Deterministic Architecture combining LLMs with explicit clinical rules; physician-verification workflow built into product design; FDA regulatory strategy for AI doctor approval; 10+ years of FDA-regulated medical technology experience from leadership team.
How they differentiate
Certuma's key differentiator is its Hybrid Deterministic Architecture (MedCanon) that adds a hard deterministic validation layer on top of LLM reasoning — unvalidated paths are rejected, uncertainty is escalated, and every decision is auditable. Unlike pure symptom-checker apps, Certuma aims for full FDA approval to autonomously diagnose AND prescribe treatments, with licensed physicians reviewing every in-scope plan before delivery.
Main competitors
Doctronic (autonomous AI doctor / prescribing), Ada Health (AI symptom assessment), Buoy Health (AI symptom checker)
Key partnerships
8VC (lead investor), partnerships with healthcare institutions (revenue model, specific partners not publicly disclosed)
Major milestones
Launched out of stealth in winter 2025/2026, Raised $10M seed round led by 8VC at $60M valuation (March 2026), Targeting FDA approval for AI doctor to diagnose 25 low-risk conditions, Building operations in US and Argentina, Argentina track: consumer-facing chatbot for diagnosis/prescribing advice with local regulator engagement (reported mid-2026)
Market positioning
Early-stage startup aiming to be the first FDA-approved autonomous AI doctor, targeting the massive global primary care market strained by a shortage of 4.3 million physicians. Positioned as clinical infrastructure rather than a symptom checker.
Geographic focus
United States (Austin HQ), Argentina (secondary market), with plans for North America, Europe, and select Asia markets
Patents and IP
MedCanon (deterministic clinical reasoning layer) — co-invented by Armando Cuesta and Joe Scanlin; Hybrid Deterministic Architecture combining LLM reasoning with validation layer
About Martin Varsavsky
5x unicorn founder with 30+ years of company-building experience; Founder and Chairman of Prelude Fertility (largest IVF network in US), Overture Life (FDA-regulated embryology automation), Gameto (FDA IND Phase 3); Previously founded Jazztel, Viatel, Eolia Renovables; European Telecommunications Entrepreneur of the Year; Columbia University Pickering Prize
Latest news about Certuma
More AI in Healthcare companies
Official website: https://www.certuma.ai